Viewing Study NCT04704245



Ignite Creation Date: 2024-05-06 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 1:53 PM
Study NCT ID: NCT04704245
Status: COMPLETED
Last Update Posted: 2021-01-11
First Post: 2021-01-05

Brief Title: Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines
Sponsor: Hallym University Kangnam Sacred Heart Hospital
Organization: Hallym University Kangnam Sacred Heart Hospital

Study Overview

Official Title: A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy
Status: COMPLETED
Status Verified Date: 2021-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Subjects were randomly assigned to groups for treatment with either an EGF-containing ointment the study group or the vehicle alone petrolatum the control group The EGF ointment included recombinant human EGF 1 μgg Random numbers used for assignment to groups were provided by the randomization function of SAS

The subjects received one session of laser treatment with a Q-switched QS 532-nm Ndyttrium aluminum garnet YAG laser of their solar lentigines after enrollment The end point of laser treatment for lentigines was immediate whitening The subjects then applied the EGF ointment or vehicle twice daily morning and evening to the lesion for 4 weeks after laser treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None